These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 17764483)

  • 1. Modeling longitudinal biomarker data from multiple assays that have different known detection limits.
    Albert PS
    Biometrics; 2008 Jun; 64(2):527-37. PubMed ID: 17764483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved protection against simian immunodeficiency virus mucosal challenge in macaques primed with a DNA vaccine and boosted with the recombinant modified vaccinia virus Ankara and recombinant Semliki Forest virus.
    Martinon F; Brochard P; Ripaux M; Delache B; Aurégan G; Vaslin B; Le Grand R
    Vaccine; 2008 Jan; 26(4):532-45. PubMed ID: 18093703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A framework for the joint modeling of longitudinal diagnostic outcome data and latent infection status: application to investigating the temporal relationship between infection and disease.
    Jones G; Johnson WO; Vink WD; French N
    Biometrics; 2012 Jun; 68(2):371-9. PubMed ID: 22004274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric approaches for joint modeling of longitudinal and survival data with time-varying coefficients.
    Song X; Wang CY
    Biometrics; 2008 Jun; 64(2):557-66. PubMed ID: 17725812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral outcome of simian-human immunodeficiency virus SHIV-89.6P adapted to cynomolgus monkeys.
    Borsetti A; Baroncelli S; Maggiorella MT; Bellino S; Moretti S; Sernicola L; Belli R; Ridolfi B; Farcomeni S; Negri DR; Cafaro A; Ensoli B; Titti F
    Arch Virol; 2008; 153(3):463-72. PubMed ID: 18080858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian analysis of serial dilution assays.
    Gelman A; Chew GL; Shnaidman M
    Biometrics; 2004 Jun; 60(2):407-17. PubMed ID: 15180666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint inference for nonlinear mixed-effects models and time to event at the presence of missing data.
    Wu L; Hu XJ; Wu H
    Biostatistics; 2008 Apr; 9(2):308-20. PubMed ID: 17728318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged survival of vaccinated macaques after oral SIVmac239 challenge regardless of viremia control in the chronic phase.
    Suh YS; Park KS; Sauermann U; Kim KS; Ahn SS; Franz M; Schulte R; Wilfingseder D; Stoiber H; Uberla K; Hunsmann G; Stahl-Hennig C; Sung YC
    Vaccine; 2008 Dec; 26(51):6690-8. PubMed ID: 18694796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sample size determination for hierarchical longitudinal designs with differential attrition rates.
    Roy A; Bhaumik DK; Aryal S; Gibbons RD
    Biometrics; 2007 Sep; 63(3):699-707. PubMed ID: 17825003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of biomarker measurement error on epidemiological studies.
    White E
    IARC Sci Publ; 1997; (142):73-93. PubMed ID: 9354913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of multiple assays subject to detection limits with regression modeling in assessing the relationship between exposure and outcome.
    Albert PS; Harel O; Perkins N; Browne R
    Epidemiology; 2010 Jul; 21 Suppl 4(Suppl 4):S35-43. PubMed ID: 20386105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mixed models for longitudinal left-censored repeated measures.
    Thiébaut R; Jacqmin-Gadda H
    Comput Methods Programs Biomed; 2004 Jun; 74(3):255-60. PubMed ID: 15135576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired astrocytes and diffuse activation of microglia in the cerebral cortex in simian immunodeficiency virus-infected Macaques without simian immunodeficiency virus encephalitis.
    Xing HQ; Mori K; Sugimoto C; Ono F; Izumo K; Kuboda R; Izumo S
    J Neuropathol Exp Neurol; 2008 Jun; 67(6):600-11. PubMed ID: 18520778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robustness of a parametric model for informatively censored bivariate longitudinal data under misspecification of its distributional assumptions: A simulation study.
    Pantazis N; Touloumi G
    Stat Med; 2007 Dec; 26(30):5473-85. PubMed ID: 18058854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Joint analysis of multiple longitudinal outcomes: application of a latent class model.
    Putter H; Vos T; de Haes H; van Houwelingen H
    Stat Med; 2008 Dec; 27(29):6228-49. PubMed ID: 18816496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal prior to systemic application of recombinant adenovirus boosting is more immunogenic than systemic application twice but confers similar protection against SIV-challenge in DNA vaccine-primed macaques.
    Schulte R; Suh YS; Sauermann U; Ochieng W; Sopper S; Kim KS; Ahn SS; Park KS; Stolte-Leeb N; Hunsmann G; Sung YC; Stahl-Hennig C
    Virology; 2009 Jan; 383(2):300-9. PubMed ID: 19027133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postinfection passive transfer of KD-247 protects against simian/human immunodeficiency virus-induced CD4+ T-cell loss in macaque lymphoid tissue.
    Murakami T; Eda Y; Nakasone T; Ami Y; Someya K; Yoshino N; Kaizu M; Izumi Y; Matsui H; Shinohara K; Yamamoto N; Honda M
    AIDS; 2009 Jul; 23(12):1485-94. PubMed ID: 19528788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine-induced, simian immunodeficiency virus-specific CD8+ T cells reduce virus replication but do not protect from simian immunodeficiency virus disease progression.
    Engram JC; Dunham RM; Makedonas G; Vanderford TH; Sumpter B; Klatt NR; Ratcliffe SJ; Garg S; Paiardini M; McQuoid M; Altman JD; Staprans SI; Betts MR; Garber DA; Feinberg MB; Silvestri G
    J Immunol; 2009 Jul; 183(1):706-17. PubMed ID: 19542473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proposal for levels of evidence schema for validation of a soluble biomarker reflecting damage endpoints in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis, and recommendations for study design.
    Maksymowych WP; Fitzgerald O; Wells GA; Gladman DD; Landewé R; Ostergaard M; Taylor WJ; Christensen R; Tak PP; Boers M; Syversen SW; Bathon JM; Ritchlin CJ; Mease PJ; Bykerk VP; Garnero P; Geusens P; El-Gabalawy H; Aletaha D; Inman RD; Kraus VB; Kvien TK; van der Heijde D
    J Rheumatol; 2009 Aug; 36(8):1792-9. PubMed ID: 19671814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Model-based imputation approach for data analysis in the presence of non-detects.
    Krishnamoorthy K; Mallick A; Mathew T
    Ann Occup Hyg; 2009 Apr; 53(3):249-63. PubMed ID: 19181626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.